Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

A 69-year-old man with sinus infection and fainting spells was diagnosed with a rare kidney disease, treated with steroids and a specific drug, which improved his condition.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.